Skip to main content
logo
CRISM Therapeutics Corporation (AIM:CRTX)
London flag London · Delayed Price · Currency is GBP · Price in GBX
9.53
-0.22 (-2.26%)
Sep 25, 2026, 1:49 PM GMT

CRISM Therapeutics Financials Overview

Millions GBP. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
0.350.230.030.05--
Revenue Growth
52.38%824.00%-44.44%---
Gross Profit
0.230.130.020.01--
Operating Income
-2.4-1.88-0.88-0.17-1.85-1.32
Net Income
-2.39-1.9-0.61-0.2-2.5-0.89
Earnings Per Share
-0.05-0.05-0.02-12.25-0.29-0.10
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.271.131.2802.894.93
Total Debt
---0.7--
Net Cash (Debt)
2.271.131.28-0.72.894.93
Net Cash Growth
101.15%-12.01%---41.42%141.49%
Net Cash Per Share
0.050.030.04-43.500.330.57

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-2.58-1.97-0.93-0.1-2.92-1.35
Capital Expenditures
------0.31
Free Cash Flow
-2.58-1.97-0.93-0.1-2.92-1.67
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
64.20%56.71%84.00%28.89%--
Operating Margin
-681.25%-812.99%-3520.00%-377.78%--
Pretax Margin
-681.25%-812.99%-2372.00%-448.89%--
Profit Margin
-677.84%-823.81%-2428.00%-435.56%--
FCF Margin
-732.67%-851.51%-3732.00%-217.78%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
21.9322.40143.7827.86--